Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ.
Wassberg C, Thörn M, Yuen J, Hakulinen T, Ringborg U.
Int J Cancer. 1999 Oct 29;83(3):314-7. doi: 10.1002/(sici)1097-0215(19991029)83:3<314::aid-ijc5>3.0.co;2-9.
PMID:10495422
In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Oba T, Makino K, Kajihara R, Yokoi T, Araki R, Abe M, Minderman H, Chang AE, Odunsi K, Ito F.